These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7702632)

  • 21. Dopamine D2 receptor binding in adrenal medulla: characterization using [3H]spiperone.
    Quik M; Bergeron L; Mount H; Philie J
    Biochem Pharmacol; 1987 Nov; 36(21):3707-13. PubMed ID: 2960326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential affinities of molindone, metoclopramide and domperidone for classes of [3H]spiroperidol binding sites in rat striatum: evidence for pharmacologically distinct classes of receptors.
    Rosenfeld MR; Dvorkin B; Klein PN; Makman MH
    Brain Res; 1982 Mar; 235(1):205-11. PubMed ID: 6145486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroleptic affinities for human brain receptors and their use in predicting adverse effects.
    Richelson E
    J Clin Psychiatry; 1984 Aug; 45(8):331-6. PubMed ID: 6146602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Irreversible blockade of [3H]spiperone- but not [3H]dopamine-labeled dopamine receptors with phenoxybenzamine.
    Titeler M
    Biochem Pharmacol; 1981 Nov; 30(22):3031-7. PubMed ID: 7337719
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of antipsychotic drugs on dopamine-receptors on caudate calf].
    Guo QY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Oct; 25(5):296-9, 317-8. PubMed ID: 1363315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine D2 receptors in substantia nigra in schizophrenia.
    Owen R; Owen F; Poulter M; Crow TJ
    Brain Res; 1984 May; 299(1):152-4. PubMed ID: 6144367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic continuous administration of neuroleptic drugs alters cerebral dopamine receptors and increases spontaneous dopaminergic action in the striatum.
    Murugaiah K; Theodorou A; Mann S; Clow A; Jenner P; Marsden CD
    Nature; 1982 Apr; 296(5857):570-2. PubMed ID: 6122161
    [No Abstract]   [Full Text] [Related]  

  • 28. Neuroleptic receptors: stereoselectivity for neuroleptic enantiomers.
    Seeman P; Westman K; Protiva M; Jílek J; Jain PC; Saxena AK; Anand N; Humber L; Philipp A
    Eur J Pharmacol; 1979 Jun; 56(3):247-51. PubMed ID: 38971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The binding of 3H-spiperone to lymphocytes in patients with schizophrenia and first-degree relatives: in search of a genetic marker].
    Heinze G; King GB; Huerto L; Ortega H; Cortés J; Ariza JR
    Gac Med Mex; 1994; 130(4):241-5. PubMed ID: 8964331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and dopamine receptors binding affinity of 2-(3-fluoro-4-hydroxyphenyl)ethylamine and its N-alkyl derivatives.
    Cardellini M; Cingolani GM; Claudi F; Perlini V; Balduini W; Cattabeni F
    Farmaco Sci; 1988 Jan; 43(1):49-59. PubMed ID: 2899520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioreceptor labeling of pre- and postsynaptic dopamine receptors.
    Titeler M; Seeman P
    Adv Biochem Psychopharmacol; 1980; 24():159-65. PubMed ID: 6996440
    [No Abstract]   [Full Text] [Related]  

  • 32. Trapping of labelled ligands in intact cells: a pitfall in binding studies.
    Maloteaux JM; Gossuin A; Waterkeyn C; Laduron PM
    Biochem Pharmacol; 1983 Sep; 32(17):2543-8. PubMed ID: 6615549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain receptors for dopamine and neuroleptics.
    Seeman P; Titeler M; Tedesco J; Weinreich P; Sinclair D
    Adv Biochem Psychopharmacol; 1978; 19():167-76. PubMed ID: 29446
    [No Abstract]   [Full Text] [Related]  

  • 34. Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes.
    Tam SW; Cook L
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5618-21. PubMed ID: 6147851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of dopamine receptor binding by ascorbic acid.
    Madras BK; Chan B
    Adv Biochem Psychopharmacol; 1983; 37():275-87. PubMed ID: 6138950
    [No Abstract]   [Full Text] [Related]  

  • 36. Absence of dopamine and muscarinic receptors on human lymphocytes.
    Maloteaux JM; Waterkein C; Laduron PM
    Arch Int Pharmacodyn Ther; 1982 Jul; 258(1):174-6. PubMed ID: 7138143
    [No Abstract]   [Full Text] [Related]  

  • 37. Identity and properties of multiple neuroleptic-binding sites in rat limbic brain areas [proceedings].
    Leysen JE
    Arch Int Physiol Biochim; 1979 Oct; 87(4):822-4. PubMed ID: 93926
    [No Abstract]   [Full Text] [Related]  

  • 38. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors.
    Malmberg A; Jackson DM; Eriksson A; Mohell N
    Mol Pharmacol; 1993 May; 43(5):749-54. PubMed ID: 8099194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine receptors on isolated membranes of rat lymphocytes.
    Ovadia H; Abramsky O
    J Neurosci Res; 1987; 18(1):70-4. PubMed ID: 3682030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.